SLI
2.125,23
PKT
-6,40
PKT
-0,30
%
Werbung
Analysen zu SLI-Werten
Datum | Rating | Analyst | |
---|---|---|---|
13.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
13.04.23 | Givaudan Sell | UBS AG | |
13.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
12.04.23 | Swiss Re Overweight | JP Morgan Chase & Co. | |
12.04.23 | Givaudan Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
12.04.23 | ABB (Asea Brown Boveri) Buy | UBS AG | |
12.04.23 | Novartis Neutral | JP Morgan Chase & Co. | |
11.04.23 | Novartis Underweight | Barclays Capital | |
11.04.23 | Roche Underweight | JP Morgan Chase & Co. | |
11.04.23 | UBS Overweight | JP Morgan Chase & Co. | |
06.04.23 | ABB (Asea Brown Boveri) Equal Weight | Barclays Capital | |
06.04.23 | Zurich Insurance Buy | UBS AG | |
06.04.23 | Givaudan Neutral | JP Morgan Chase & Co. | |
05.04.23 | Richemont Buy | UBS AG | |
05.04.23 | ABB (Asea Brown Boveri) Buy | Goldman Sachs Group Inc. | |
05.04.23 | Richemont Overweight | JP Morgan Chase & Co. | |
05.04.23 | Nestlé Market-Perform | Bernstein Research | |
05.04.23 | Roche Buy | Joh. Berenberg, Gossler & Co. KG (Berenberg Bank) | |
05.04.23 | Zurich Insurance Neutral | Goldman Sachs Group Inc. | |
05.04.23 | Nestlé Market-Perform | Bernstein Research | |
03.04.23 | ABB (Asea Brown Boveri) Neutral | JP Morgan Chase & Co. | |
03.04.23 | ABB (Asea Brown Boveri) Hold | Deutsche Bank AG | |
03.04.23 | Zurich Insurance Overweight | Barclays Capital | |
30.03.23 | Givaudan Sell | Goldman Sachs Group Inc. | |
30.03.23 | Givaudan Underweight | Barclays Capital | |
29.03.23 | UBS Overweight | JP Morgan Chase & Co. | |
29.03.23 | Givaudan Sell | UBS AG | |
29.03.23 | Nestlé Buy | UBS AG | |
29.03.23 | UBS Buy | Goldman Sachs Group Inc. | |
29.03.23 | Roche Underweight | JP Morgan Chase & Co. | |
29.03.23 | UBS Sector Perform | RBC Capital Markets | |
28.03.23 | Novartis Neutral | UBS AG | |
28.03.23 | Givaudan Hold | Deutsche Bank AG | |
28.03.23 | Novartis Hold | Deutsche Bank AG | |
27.03.23 | Givaudan Underperform | Jefferies & Company Inc. | |
27.03.23 | Nestlé Neutral | Credit Suisse Group | |
27.03.23 | Givaudan Underweight | JP Morgan Chase & Co. | |
27.03.23 | Roche Equal Weight | Barclays Capital | |
27.03.23 | Novartis Buy | Jefferies & Company Inc. | |
24.03.23 | UBS Hold | Jefferies & Company Inc. |